GlassScriptPhysician profile
Jenny Murphy Stokes
NPI 1811471360
$3,371.31
in general payments reported to CMS, 2019-2025
31 companies · $850 in 2025
The $850 reported for 2025 was more than what 83% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $795 · 2022: $627 · 2023: $911 · 2024: $189 · 2025: $850.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,949.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,949.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $684.23 | 2021-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $396.13 | 2021-2025 | Relistor, Xifaxan, Trulance |
| Amgen INC. | $279.23 | 2021-2025 | Otezla, Repatha |
| Glaxosmithkline, LLC. | $252.83 | 2021-2023 | Trelegy Ellipta |
| Averitas Pharma INC. | $238.08 | 2025 | Qutenza |
| Otsuka America Pharmaceutical, INC. | $190.99 | 2021-2024 | Rexulti |
| Indivior INC. | $161.52 | 2022-2025 | Sublocade |
| Boston Scientific Corporation | $131.49 | 2025 | Intracept |
| Astrazeneca Pharmaceuticals LP | $131.31 | 2022-2024 | Airsupra, Farxiga |
| Livanova USA, INC. | $130.35 | 2023 | Tandemlife |
| Radius Health, INC. | $119.10 | 2021-2022 | |
| Almatica Pharma LLC | $84.64 | 2021-2023 | Loreev Xr |
| Valinor Pharma, LLC | $75.54 | 2024-2025 | Movantik |
| Globus Medical, INC. | $57.34 | 2025 | Omnia, Senza |
| Lundbeck LLC | $53.46 | 2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $46.27 | 2023 | Auvelity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.33 | 2022 | |
| Exact Sciences Corporation | $33.49 | 2023 | Cologuard Collection Kit |
| Azurity Pharmaceuticals, INC. | $32.71 | 2023 | Horizant |
| Novartis Pharmaceuticals Corporation | $28.57 | 2023 | |
| Lilly USA, LLC | $27.68 | 2021 | |
| Aurinia Pharma U.S., INC. | $24.84 | 2021 | |
| Sunovion Pharmaceuticals INC. | $24.81 | 2021 | |
| Biotronik Nro, INC. | $22.76 | 2025 | Prospera |
| Medtronic, INC. | $22.57 | 2022 | |
| Hikma Pharmaceuticals USA | $15.43 | 2024 | Kloxxado, Ryaltris |
| Pfizer INC. | $15.00 | 2021 | |
| Eisai INC. | $14.60 | 2021 | |
| Alexion Pharmaceuticals, INC. | $14.48 | 2023 | Strensiq |
| Novo Nordisk INC | $13.29 | 2023 | Rybelsus, Ozempic |
| Biodelivery Sciences International, INC. | $13.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenny Stokes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.